Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study

Thijs F van Haaps; Didier Collard; Frits H M van Osch; Saskia Middeldorp; Michiel Coppens; Martijn D de Kruif; Eline A Vlot; Renée A Douma; Hugo Ten Cate; Nicole P Juffermans; Niels Gritters; Alexander P Vlaar; Auke C Reidinga; Marjolein A Heuvelmans; Matthijs Oudkerk; Harry R Büller; Joop P W van den Bergh; Arno Maas; Marije Ten Wolde; Suat Simsek; Corona Research Fund Amsterdam UMC; Martijn Beudel; Nick van Es; Dutch COVID & Thrombosis Coalition

doi:10.1016/j.thromres.2021.10.006

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study

Thromb Res. 2021 Dec:208:35-38. doi: 10.1016/j.thromres.2021.10.006. Epub 2021 Oct 15.

Authors

Thijs F van Haaps¹, Didier Collard², Frits H M van Osch³, Saskia Middeldorp⁴, Michiel Coppens², Martijn D de Kruif⁵, Eline A Vlot⁶, Renée A Douma⁷, Hugo Ten Cate⁸, Nicole P Juffermans⁹, Niels Gritters¹⁰, Alexander P Vlaar¹¹, Auke C Reidinga¹², Marjolein A Heuvelmans¹³, Matthijs Oudkerk¹³, Harry R Büller², Joop P W van den Bergh¹⁴, Arno Maas¹⁴, Marije Ten Wolde⁷, Suat Simsek¹⁵; Corona Research Fund Amsterdam UMC; Martijn Beudel¹⁶, Nick van Es²; Dutch COVID & Thrombosis Coalition

Affiliations

¹ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: t.f.vanhaaps@amsterdamumc.nl.
² Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands.
³ Department of Clinical Epidemiology, VieCuri Medical Center, Venlo, the Netherlands & NUTRIM, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
⁴ Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, the Netherlands.
⁵ Department of Pulmonary Medicine, Zuyderland Medical Centre, Heerlen, the Netherlands.
⁶ Department of Anaesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Nieuwegein, the Netherlands.
⁷ Department of Internal Medicine, Flevo Hospital, Almere, the Netherlands.
⁸ Department of Internal Medicine, Cardiovascular Research Institute Maastricht (CARIM) and Maastricht University Medical Center, Maastricht, the Netherlands.
⁹ Department of Intensive Care Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands; Department of Intensive Care Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
¹⁰ Department of Intensive Care Medicine, Treant Zorggroep, Emmen, the Netherlands.
¹¹ Department of Intensive Care Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
¹² Department of Anaesthesiology, Martini Hospital, Groningen, the Netherlands.
¹³ Institute of Diagnostic Accuracy (iDNA), Groningen, the Netherlands.
¹⁴ Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands.
¹⁵ Department of Internal Medicine, Northwest Clinic, Alkmaar, the Netherlands.
¹⁶ Department of Neurology, Amsterdam UMC, Amsterdam Neuroscience Institute, Amsterdam, the Netherlands.

No abstract available

Keywords: Anticoagulants; COVID-19; Mortality; SARS-CoV-2; Thrombosis.

Publication types

Letter
Comment

MeSH terms

Anticoagulants / therapeutic use
COVID-19*
Hospital Mortality
Humans
Retrospective Studies
SARS-CoV-2

Substances

Anticoagulants